Frequent detection of anti-recoverin cytotoxic T-lymphocyte precursors in peripheral blood of cancer patients by using an HLA-A24-recoverin tetramer

Cancer Immunology, Immunotherapy

Volumn 51, Issue 5, 2002, Pages 282-290

  Rong, Shunshui ^a   Ikeda, Hideyuki ^a   Sato, Yuriko ^a   Hirohashi, Yoshihiko ^a   Takamura, Yukio ^a   Sahara, Hiroeki ^a   Sato, Takashi ^b   Maeda, Akiko ^a   Ohguro, Hiroshi ^c   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hokkaido Prefectural Haboro Hospital   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

CTL precursor; HLA A24; Recoverin; Tetramer

Indexed keywords

HLA A ANTIGEN; HLA A24 ANTIGEN; RECOVERIN; TETRAMER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STOMACH CANCER;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD8; CALCIUM-BINDING PROTEINS; CELL SEPARATION; EYE PROTEINS; FLOW CYTOMETRY; HIPPOCALCIN; HLA-A ANTIGENS; HUMANS; LIPOPROTEINS; MELANOMA; MIDDLE AGED; NEOPLASMS; NERVE TISSUE PROTEINS; PEPTIDES; RECOVERIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0036329097     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0282-6     Document Type: Article

References (33)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. + T cells with soluble HLA- A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy
3. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity
4. Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer
5. A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3
6. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies
7. Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma
8. The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self-tolerance on the TCR repertoire
9. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
10. High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival
11. Rhodopsin phosphorylation as a mechanism of cyclic GMP phosphodiesterase regulation by S-modulin
12. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
13. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma
14. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines
15. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome
16. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
17. A new look at T cells
18. Isolation of human retinal genes: Recoverin cDNA and gene
19. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
20. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
21. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
22. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
23. Structural and enzymatic aspects of rhodopsin phosphorylation
24. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy
25. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy
26. Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy
27. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
28. Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues
29. Identification of natural antigenic peptides of a human gastric signet ring cell carcinoma recognized by HLA-A31-restricted cytotoxic T lymphocytes
30. An antigen-targeted approach to adoptive transfer therapy of cancer
31. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent
32. Characterization of a small-cell-lung-carcinoma cell line from a patient with cancer-associated retinopathy
33. Use of fluorogenic histo-compatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens